Your search returned 2 results.

Results
	1.	A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study. [electronic resource] by Antolín, Silvia Mel, Ramón Ramos, Manuel García-Palomo, Andrés Almanza, Concepción de Paz, Laura Calvo, Lourdes Alvarez, Elena González, Ana García-Mata, Jesús Producer: 20120104 In: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study. [electronic resource] by Morales, Serafín Lorenzo, Antonio Ramos, Manuel Ballesteros, Pedro Méndez, Miguel Almanza, Concepción Castellanos, Javier Moreno-Nogueira, José Andrés Casal, Joaquín Lizón, José Oltra, Amparo Frau, Adolfo Machengs, Ignacio Galán, Antonio Belón, Joaquín Llorca, Cristina Producer: 20040203 In: Cancer chemotherapy and pharmacology vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search